A Novel, High Sensitivity Marker, hsPro-C2, Of Cartilage Formation, Was Developed And Tested In A Phase II Clinical Trial Of PTH

Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningfagfællebedømt

Standard

A Novel, High Sensitivity Marker, hsPro-C2, Of Cartilage Formation, Was Developed And Tested In A Phase II Clinical Trial Of PTH. / Luo, Yunyun; He, Y; Byrjalsen, I; Henriksen, K; Gudmann, N S; Mobasheri, A; Hansen, G; Karsdala, M; Bay-Jensen, A-C.

I: Osteoarthritis and Cartilage, Bind 25, Nr. Suplement 1, 2017, s. S106-S107.

Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningfagfællebedømt

Harvard

Luo, Y, He, Y, Byrjalsen, I, Henriksen, K, Gudmann, NS, Mobasheri, A, Hansen, G, Karsdala, M & Bay-Jensen, A-C 2017, 'A Novel, High Sensitivity Marker, hsPro-C2, Of Cartilage Formation, Was Developed And Tested In A Phase II Clinical Trial Of PTH' Osteoarthritis and Cartilage, bind 25, nr. Suplement 1, s. S106-S107.

APA

Luo, Y., He, Y., Byrjalsen, I., Henriksen, K., Gudmann, N. S., Mobasheri, A., ... Bay-Jensen, A-C. (2017). A Novel, High Sensitivity Marker, hsPro-C2, Of Cartilage Formation, Was Developed And Tested In A Phase II Clinical Trial Of PTH. Osteoarthritis and Cartilage, 25(Suplement 1), S106-S107.

Vancouver

Luo Y, He Y, Byrjalsen I, Henriksen K, Gudmann NS, Mobasheri A o.a. A Novel, High Sensitivity Marker, hsPro-C2, Of Cartilage Formation, Was Developed And Tested In A Phase II Clinical Trial Of PTH. Osteoarthritis and Cartilage. 2017;25(Suplement 1):S106-S107.

Author

Luo, Yunyun ; He, Y ; Byrjalsen, I ; Henriksen, K ; Gudmann, N S ; Mobasheri, A ; Hansen, G ; Karsdala, M ; Bay-Jensen, A-C. / A Novel, High Sensitivity Marker, hsPro-C2, Of Cartilage Formation, Was Developed And Tested In A Phase II Clinical Trial Of PTH. I: Osteoarthritis and Cartilage. 2017 ; Bind 25, Nr. Suplement 1. s. S106-S107.

Bibtex

@article{54e84d1d6a26407b804c383575aee8fc,
title = "A Novel, High Sensitivity Marker, hsPro-C2, Of Cartilage Formation, Was Developed And Tested In A Phase II Clinical Trial Of PTH",
keywords = "The Faculty of Health and Medical Sciences",
author = "Yunyun Luo and Y He and I Byrjalsen and K Henriksen and Gudmann, {N S} and A Mobasheri and G Hansen and M Karsdala and A-C Bay-Jensen",
year = "2017",
language = "English",
volume = "25",
pages = "S106--S107",
journal = "Osteoarthritis and Cartilage",
issn = "1063-4584",
publisher = "Elsevier",
number = "Suplement 1",

}

RIS

TY - ABST

T1 - A Novel, High Sensitivity Marker, hsPro-C2, Of Cartilage Formation, Was Developed And Tested In A Phase II Clinical Trial Of PTH

AU - Luo, Yunyun

AU - He, Y

AU - Byrjalsen, I

AU - Henriksen, K

AU - Gudmann, N S

AU - Mobasheri, A

AU - Hansen, G

AU - Karsdala, M

AU - Bay-Jensen, A-C

PY - 2017

Y1 - 2017

KW - The Faculty of Health and Medical Sciences

M3 - Conference abstract in journal

VL - 25

SP - S106-S107

JO - Osteoarthritis and Cartilage

JF - Osteoarthritis and Cartilage

SN - 1063-4584

IS - Suplement 1

ER -

ID: 189697784